Prospector Partners LLC Acquires Shares of 90,500 Option Care Health, Inc. (NASDAQ:OPCH)

Prospector Partners LLC acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 90,500 shares of the company's stock, valued at approximately $2,100,000. Prospector Partners LLC owned 0.05% of Option Care Health as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Wellington Management Group LLP grew its holdings in Option Care Health by 84.6% during the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares in the last quarter. Norges Bank acquired a new position in Option Care Health during the 4th quarter valued at approximately $60,219,000. Victory Capital Management Inc. grew its holdings in shares of Option Care Health by 31.1% during the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock valued at $49,310,000 after buying an additional 503,840 shares during the last quarter. Magnetar Financial LLC raised its stake in shares of Option Care Health by 23.1% in the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock worth $54,534,000 after purchasing an additional 441,265 shares during the last quarter. Finally, Trexquant Investment LP acquired a new position in Option Care Health during the fourth quarter valued at $10,161,000. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.64% of the company's stock.

Remove Ads

Option Care Health Price Performance

NASDAQ:OPCH traded down $2.10 during trading hours on Friday, reaching $31.59. 2,075,901 shares of the company were exchanged, compared to its average volume of 1,760,938. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.19 billion, a PE ratio of 26.42, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock's 50-day moving average is $33.23 and its 200-day moving average is $28.60.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities restated a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Barrington Research lifted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Finally, Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.